cramping with semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Semaglutide & Back Pain: Evidence

[PMC free article: PMC5697951] [PubMed: 28951389] 62

Other potential risks include: Increased heart rate and palpitations from phentermine's stimulant effects Insomnia and anxiety , as phentermine affects the central nervous system Hypoglycaemia risk if Rybelsus is combined with insulin or sulfonylureas Dehydration from reduced fluid intake due to appetite suppression and gastrointestinal losses There is insufficient clinical trial data examining the safety profile of this specific combination

The larger concern during breastfeeding is not drug exposure, but reduced calorie and nutrient intake due to appetite suppression

Studies have found that many patients maintain a 1015% reduction in body weight after one year of consistent use, with continued benefits beyond that when treatment is ongoing

Weight loss plateaus are normal and typically reflect metabolic adaptation

Serious side effects are rare but can include pancreatitis or thyroid issues